[go: up one dir, main page]

MX2009008545A - Sistema terapeutico transdermico para administrar ingredientes activos solubles en agua. - Google Patents

Sistema terapeutico transdermico para administrar ingredientes activos solubles en agua.

Info

Publication number
MX2009008545A
MX2009008545A MX2009008545A MX2009008545A MX2009008545A MX 2009008545 A MX2009008545 A MX 2009008545A MX 2009008545 A MX2009008545 A MX 2009008545A MX 2009008545 A MX2009008545 A MX 2009008545A MX 2009008545 A MX2009008545 A MX 2009008545A
Authority
MX
Mexico
Prior art keywords
active ingredients
therapeutic system
transdermal therapeutic
soluble active
administering water
Prior art date
Application number
MX2009008545A
Other languages
English (en)
Inventor
Bodo Asmussen
Michael Horstmann
Christoph Schmitz
Mohammad Sameti
Yves-Thorsten Przybylla
Rolf Pracht
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of MX2009008545A publication Critical patent/MX2009008545A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Obesity (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La invención se refiere a un sistema terapéutico transdérmico para la liberación controlada de ingredientes activos farmacéuticos solubles en agua procedentes de una fase acuosa, que comprende una capa de refuerzo oclusiva, un dispositivo central orientado hacia la piel para liberar el agente, una capa adhesiva que rodea concéntricamente el dispositivo de suministro y una película protectora removible; dicho dispositivo está elaborado de una fase sólida estacionaria y una fase líquida que contiene el ingrediente activo en solución acuosa, la fase sólida estando formada de un sólido con una estructura con la apariencia de vellón o de esponja.
MX2009008545A 2007-02-08 2008-01-19 Sistema terapeutico transdermico para administrar ingredientes activos solubles en agua. MX2009008545A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102007006244A DE102007006244B4 (de) 2007-02-08 2007-02-08 Transdermales Therapeutisches System zur Verabreichung wasserlöslicher Wirkstoffe
PCT/EP2008/000392 WO2008095597A2 (de) 2007-02-08 2008-01-19 Transdermale therapeutisches system zur verabreichung wasserlöslicher wirkstoffe

Publications (1)

Publication Number Publication Date
MX2009008545A true MX2009008545A (es) 2009-08-18

Family

ID=39278259

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009008545A MX2009008545A (es) 2007-02-08 2008-01-19 Sistema terapeutico transdermico para administrar ingredientes activos solubles en agua.

Country Status (13)

Country Link
US (1) US11612571B2 (es)
EP (1) EP2114385B1 (es)
JP (2) JP2010518033A (es)
KR (1) KR101452536B1 (es)
CN (1) CN101674815B (es)
AU (1) AU2008213446B2 (es)
BR (1) BRPI0806856A2 (es)
CA (1) CA2676217C (es)
DE (1) DE102007006244B4 (es)
ES (1) ES2795372T3 (es)
MX (1) MX2009008545A (es)
WO (1) WO2008095597A2 (es)
ZA (1) ZA200904563B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102009056745A1 (de) * 2009-12-04 2011-06-09 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System für die Verabreichung von Peptiden
DE102010024105A1 (de) * 2010-06-17 2011-12-22 Grünenthal GmbH Transdermale Verabreichung von Memantin

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3406497A1 (de) * 1984-02-23 1985-09-05 Mueller Bernhard Willi Werner Hochdisperse pharmazeutische mehrkomponentensysteme und verfahren zu ihrer herstellung
US4597961A (en) 1985-01-23 1986-07-01 Etscorn Frank T Transcutaneous application of nicotine
US4784857A (en) * 1986-06-03 1988-11-15 Smith And Nephew Associated Companies Plc Drug delivery device, its preparation and use
DE3762480D1 (de) * 1986-08-23 1990-06-07 Arno W Latzke Mittel zur applikation von transdermal resorbierbaren wirkstoffen.
JPH01224312A (ja) 1988-03-01 1989-09-07 Tadashi Ijima 治療具
DE3844247A1 (de) 1988-12-29 1990-07-12 Minnesota Mining & Mfg Vorrichtung, insbesondere pflaster zum transdermalen verabreichen eines medikaments
DE3908432A1 (de) * 1989-03-14 1990-09-27 Lohmann Therapie Syst Lts Pflaster als therapeutisches system zur verabreichung von wirkstoffen an die haut mit einer abgestuften wirkstoffabgabe, verfahren zu seiner herstellung sowie verwendung
FR2650747B1 (fr) 1989-08-11 1994-02-11 Oreal Film composite pour traitement cutane local et procedes de fabrication correspondants
DE4110027C2 (de) * 1991-03-27 1996-08-29 Lohmann Therapie Syst Lts Verfahren zur Konfektionierung transdermaler therapeutischer Pflaster
DE4223004A1 (de) 1992-07-13 1994-01-20 Liedtke Pharmed Gmbh Einzeldosierte halbfeste topische Arzneiform zur Transdermaltherapie
US5462743A (en) * 1992-10-30 1995-10-31 Medipro Sciences Limited Substance transfer system for topical application
US5503844A (en) * 1993-05-18 1996-04-02 Mli Acquisition Corp. Ii Foam laminate transdermal patch
JPH07250864A (ja) * 1994-03-11 1995-10-03 Tac Medical Kk 経皮吸収型製剤
JPH07277961A (ja) 1994-04-13 1995-10-24 Sekisui Chem Co Ltd 経皮吸収製剤
US5707641A (en) 1994-10-13 1998-01-13 Pharmaderm Research & Development Ltd. Formulations comprising therapeutically-active proteins or polypeptides
CA2208132A1 (en) * 1994-12-21 1996-06-27 Theratech, Inc. Transdermal delivery system with adhesive overlay and peel seal disc
TW592729B (en) 1995-04-06 2004-06-21 Janssen Pharmaceutica Nv Rate-controlled transdermal administration of risperidone
US6087549A (en) * 1997-09-22 2000-07-11 Argentum International Multilayer laminate wound dressing
US5807570A (en) * 1995-09-29 1998-09-15 Cygnus, Inc. Transdermal administration of ropinirole and analogs thereof
US6328992B1 (en) * 1997-03-03 2001-12-11 Lawrence L. Brooke Cannabinoid patch and method for cannabis transdermal delivery
IN187032B (es) 1997-06-24 2001-12-29 Council Scient Ind Res
DE19840191A1 (de) * 1998-09-03 2000-03-09 Lohmann Therapie Syst Lts Arzneistoffhaltiges Pflaster mit drei funktionalen Schichten
DE19849823A1 (de) * 1998-10-29 2000-05-04 Lohmann Therapie Syst Lts Dermales bzw. transdermales selbstklebend ausgerüstetes Pflaster
DE19923427A1 (de) * 1999-05-21 2000-11-23 Lohmann Therapie Syst Lts Vorrichtung und Verfahren zur Steigerung der transdermalen Permeation von Arzneistoffen
US6586000B2 (en) * 1999-12-16 2003-07-01 Dermatrends, Inc. Hydroxide-releasing agents as skin permeation enhancers
US6558695B2 (en) * 1999-12-16 2003-05-06 Dermatrends, Inc. Topical and transdermal administration of peptidyl drugs using hydroxide releasing agents as permeation enhancers
US20050074487A1 (en) * 1999-12-16 2005-04-07 Tsung-Min Hsu Transdermal and topical administration of drugs using basic permeation enhancers
JP2004500360A (ja) * 1999-12-16 2004-01-08 ダーマトレンズ，　インコーポレイテッド 皮膚浸透促進剤としての水酸化物放出剤
DE10027258C1 (de) * 2000-05-31 2001-10-31 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit okklusiver wirkstoffhaltiger Schicht und nicht-okklusiver Rückschicht
US7615238B2 (en) * 2001-09-04 2009-11-10 Trommsdorff GmbH & Co. KG Arzneimitttel Plaster for the treatment of dysfunctions and disorders of nails, comprising sertaconazole
AU2003303525A1 (en) * 2002-12-31 2004-07-29 Ultra-Sonic Technologies, L.L.C. Transdermal delivery using encapsulated agent activated by ultrasound and/or heat
EP1682060A1 (en) * 2003-10-14 2006-07-26 Dermatrends, Inc. Enhancing transdermal administration of hydrophilic drugs
DE10361306A1 (de) * 2003-12-24 2005-07-28 Lts Lohmann Therapie-Systeme Ag Wundauflage und Wundschnellverband mit einem vasokonstriktorischen Inhaltsstoff, sowie Herstellungsverfahren hierfür
WO2008086341A1 (en) * 2007-01-09 2008-07-17 Pericor Therapeutics, Inc. Methods. compositions, and formulations for preventing or reducing adverse effects in a patient

Also Published As

Publication number Publication date
CA2676217A1 (en) 2008-08-14
KR101452536B1 (ko) 2014-10-21
CN101674815B (zh) 2015-07-22
CN101674815A (zh) 2010-03-17
JP2010518033A (ja) 2010-05-27
EP2114385B1 (de) 2020-03-18
AU2008213446A1 (en) 2008-08-14
EP2114385A2 (de) 2009-11-11
US11612571B2 (en) 2023-03-28
ES2795372T3 (es) 2020-11-23
BRPI0806856A2 (pt) 2016-12-06
US20100028412A1 (en) 2010-02-04
KR20090108056A (ko) 2009-10-14
ZA200904563B (en) 2010-04-28
CA2676217C (en) 2015-03-17
DE102007006244B4 (de) 2012-03-15
JP2014012711A (ja) 2014-01-23
WO2008095597A3 (de) 2009-11-26
AU2008213446B2 (en) 2013-05-30
DE102007006244A1 (de) 2008-08-14
WO2008095597A2 (de) 2008-08-14

Similar Documents

Publication Publication Date Title
JP5881935B2 (ja) 活性物質の利用率及び用量精度の高い経皮治療システム
MX2009010561A (es) Sistema de liberacion transdermal de droga para principios activos liquidos.
DK2613784T3 (da) Indretning til transdermal indgivelse af lægemiddel
WO2008049516A3 (de) Transdermales therapeutisches system enthaltend norelgestromin zur kontrazeption und hormonsubstitution
WO2011029948A3 (de) Transdermales therapeutisches system zur verabreichung von fentanyl oder einem analogstoff davon
CN103596560B (zh) 薄层和液体结合的透皮给药系统
MY161895A (en) Dermal film-forming liquid formulations for drug release to skin
TW201000153A (en) Composition and methods for the transdermal delivery of pharmaceutical compounds
MY183873A (en) Transdermal therapeutic system for application of an agent
NZ611920A (en) Percutaneous absorption preparation containing rivastigmine
Monika et al. Transdermal drug delivery system with formulation and evaluation aspects: Overview
BRPI0411032A (pt) composição adesiva hidrófila, artigo médico, método para a fabricação da composição adesiva, e, dispositivo de administração transdérmica
MX2009008993A (es) Dispositivo para la administracion percutanea de bisoprolol.
TWI660751B (zh) 貼附劑
TW200738287A (en) Nicotine transdermal delivery system
MX2009008545A (es) Sistema terapeutico transdermico para administrar ingredientes activos solubles en agua.
BR112012014107A2 (pt) sistema terapêutico transdérmico para administração de peptídeos
WO2012111996A3 (ko) 갈란타민 또는 그의 염을 함유하는 경피흡수제제
JPWO2017164084A1 (ja) 誤用防止特性を有する貼付製剤
CA2949568C (en) Transdermal therapeutic system containing lavender oil
WO2009095057A3 (de) Transdermales therapeutisches system mit harnstoff-komponente
MY148823A (en) Medically active plaster
UA98480C2 (en) Medically active plaster with etofenamat
Patel et al. A FACET UPSHOT ON TRANSDERMAL THERAPEUTIC SYSTEMS: IN MIDDLE OF UPDATED PERSPECTIVE
HK1258590B (zh) 贴剂

Legal Events

Date Code Title Description
FG Grant or registration